Drug intelligence / Profile preview

Atrosia

Development stage
Unknown
Lead developer
Weber & Weber
Modality
Small Molecules
Administration
Oral
01

Overview

Atrosia is a herbal medicinal product developed by Weber & Weber Biologische Arzneimittel, containing a concentrated dry extract of *Harpagophytum procumbens* (Devil's Claw) secondary roots. It is utilized for the supportive treatment of degenerative musculoskeletal conditions, including osteoarthritis and chronic joint pain. The therapeutic efficacy is largely attributed to iridoid glycosides, particularly harpagoside, which exhibit anti-inflammatory and analgesic properties by inhibiting the synthesis of pro-inflammatory mediators such as prostaglandins and leukotrienes through the modulation of cyclooxygenase and lipoxygenase pathways. It is registered in Germany as a pharmaceutical product for the relief of joint wear and tear.

Brand names
Atrosia
Other names
Harpagophytum procumbens root extractDevil's claw extractTeufelskralle-Extrakt
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Atrosia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atrosia.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call